These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16306155)

  • 1. Origin of ICU acquired paresis determined by direct muscle stimulation.
    Lefaucheur JP; Nordine T; Rodriguez P; Brochard L
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):500-6. PubMed ID: 16306155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular involvement in COVID-19 critically ill patients.
    Cabañes-Martínez L; Villadóniga M; González-Rodríguez L; Araque L; Díaz-Cid A; Ruz-Caracuel I; Pian H; Sánchez-Alonso S; Fanjul S; Del Álamo M; Regidor I
    Clin Neurophysiol; 2020 Dec; 131(12):2809-2816. PubMed ID: 33137571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The predominance of myopathy as a cause of intensive-care-unit-acquired paralysis: the diagnostic value of direct muscle stimulation].
    Nordine T; Lefaucheur JP
    Rev Neurol (Paris); 2007 Feb; 163(2):181-7. PubMed ID: 17351537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Critical illness myopathy. Neurophysiological and muscular biopsy assessment in 33 patients].
    Fernández-Lorente J; Esteban A; Salinero E; Traba A; Prieto J; Palencia E
    Rev Neurol; 2010 Jun; 50(12):718-26. PubMed ID: 20533250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intensive care unit-acquired weakness: development of polyneuropathy and myopathy in critically ill patients].
    Takei T
    Brain Nerve; 2014 Feb; 66(2):161-70. PubMed ID: 24523314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term recovery In critical illness myopathy is complete, contrary to polyneuropathy.
    Koch S; Wollersheim T; Bierbrauer J; Haas K; Mörgeli R; Deja M; Spies CD; Spuler S; Krebs M; Weber-Carstens S
    Muscle Nerve; 2014 Sep; 50(3):431-6. PubMed ID: 24415656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical illness myopathy after COVID-19.
    Bagnato S; Boccagni C; Marino G; Prestandrea C; D'Agostino T; Rubino F
    Int J Infect Dis; 2020 Oct; 99():276-278. PubMed ID: 32763444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge.
    Koch S; Spuler S; Deja M; Bierbrauer J; Dimroth A; Behse F; Spies CD; Wernecke KD; Weber-Carstens S
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):287-93. PubMed ID: 20802220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes.
    Latronico N; Rasulo FA; Eikermann M; Piva S
    Crit Care; 2023 Nov; 27(1):439. PubMed ID: 37957759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical illness neuropathy in severe COVID-19: a case series.
    Bocci T; Campiglio L; Zardoni M; Botta S; Coppola S; Groppo E; Chiumello D; Priori A
    Neurol Sci; 2021 Dec; 42(12):4893-4898. PubMed ID: 34477990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.
    Friedrich O; Reid MB; Van den Berghe G; Vanhorebeek I; Hermans G; Rich MM; Larsson L
    Physiol Rev; 2015 Jul; 95(3):1025-109. PubMed ID: 26133937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis.
    Latronico N; Bolton CF
    Lancet Neurol; 2011 Oct; 10(10):931-41. PubMed ID: 21939902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuromuscular manifestations in critically ill patients].
    Smith TA; Fabricius ME
    Ugeskr Laeger; 2007 Jun; 169(23):2216-9. PubMed ID: 17592690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical illness myopathy: further evidence from muscle-fiber excitability studies of an acquired channelopathy.
    Allen DC; Arunachalam R; Mills KR
    Muscle Nerve; 2008 Jan; 37(1):14-22. PubMed ID: 17763454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical illness polyneuropathy and myopathy in pediatric intensive care: A review.
    Williams S; Horrocks IA; Ouvrier RA; Gillis J; Ryan MM
    Pediatr Crit Care Med; 2007 Jan; 8(1):18-22. PubMed ID: 17251877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of EMG and muscle biopsy in ICU weakness.
    Raghig H; Young GB; Hammond R; Nicolle M
    Neurocrit Care; 2010 Dec; 13(3):326-30. PubMed ID: 20717748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing testing methods and collection of reference data for differentiating critical illness polyneuropathy from critical illness MYOPATHIES.
    Marrero HG; Stålberg EV
    Muscle Nerve; 2016 Apr; 53(4):555-63. PubMed ID: 26311145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical Illness Neuropathy.
    Tankisi H; de Carvalho M; Z'Graggen WJ
    J Clin Neurophysiol; 2020 May; 37(3):205-207. PubMed ID: 32358246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical consequences of neuromuscular impairments in critically ill patients].
    Mesejo A; Pérez-Sancho E; Moreno E
    Nutr Hosp; 2006 May; 21 Suppl 3():104-13. PubMed ID: 16768037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive care unit-acquired weakness: unanswered questions and targets for future research.
    Piva S; Fagoni N; Latronico N
    F1000Res; 2019; 8():. PubMed ID: 31069055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.